Callan Capital, LLC Connect Biopharma Holdings LTD Transaction History
Callan Capital, LLC
- $1.36 Billion
- Q4 2024
A detailed history of Callan Capital, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Callan Capital, LLC holds 80,000 shares of CNTB stock, worth $73,600. This represents 0.01% of its overall portfolio holdings.
Number of Shares
80,000
Previous 41,823
91.28%
Holding current value
$73,600
Previous $60,000
60.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CNTB
# of Institutions
16Shares Held
3.28MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.93 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$469,8440.04% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$147,9970.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$123,9210.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$95,5790.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $50.6M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...